Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.56
-0.19 (-2.81%)
Jul 15, 2025, 4:00 PM - Market closed
Aura Biosciences Employees
As of December 31, 2024, Aura Biosciences had 109 total employees, including 106 full-time and 3 part-time employees. The number of employees increased by 20 or 22.47% compared to the previous year.
Employees
109
Change (1Y)
20
Growth (1Y)
22.47%
Revenue / Employee
n/a
Profits / Employee
-$868,771
Market Cap
406.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 109 | 20 | 22.47% |
| Dec 31, 2023 | 89 | 17 | 23.61% |
| Dec 31, 2022 | 72 | 20 | 38.46% |
| Dec 31, 2021 | 52 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AURA News
- 2 months ago - Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - GlobeNewsWire
- 2 months ago - Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewsWire
- 2 months ago - Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 2 months ago - Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors - GlobeNewsWire
- 4 months ago - Aura Biosciences, Inc (AURA) Virtual Urologic Oncology Investor Event Call (Transcript) - Seeking Alpha
- 4 months ago - Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewsWire
- 4 months ago - Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress - GlobeNewsWire